Female authorship in musculoskeletal radiology research has seen a steady climb over the last two decades—a positive trend that is indicative of progress in a field where leadership is largely dominated by males. 

A Canadian manufacturer of positron emission tomography equipment has received FDA’s OK to market a small-footprint scanner that images targeted organs bearing radiotracers at close range.

The report placed radiologists’ annual compensation 6th among the top 10 highest physician salaries.

On July 18 Fresenius Kabi announced that they are rolling out a line of generic contrast media products, starting immediately with Iodixanol Injection USP. 

Citing low health literacy as a barrier between providers and patients in overcoming healthcare disparities, DenseBreast-info.org updated their breast density materials to include more patient-friendly, “simple language.”

Per Bayer’s communications, the contrast agent is manufactured at the same site in Berlin, Germany as the Ultravist that is intended for U.S. markets, but due to its intended distribution abroad it lacks current FDA-approved labeling. 

Using CBIRS decreased interpretation times despite the radiologists who utilized them having to review the additional information the system provided.

“CMS couldn’t have picked a worse time to cut Medicare payments to physicians,” said RBMA Executive Director Bob Still.